PMH43 - COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED CENTRAL AND EASTERN EUROPEAN COUNTRIES
Abstract
Authors
B. Nemeth R. Bendes B. Nagy I.A. Deak B. Toth K. Koczian M. Horvath C. Croitoru M. Tarhajova M. Psota J. Kuchar M. Bucek Psenkova Z. Vokó